{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:16:55Z","timestamp":1772749015776,"version":"3.50.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/fpc.0000000000000006","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T06:59:28Z","timestamp":1382079568000},"page":"666-674","source":"Crossref","is-referenced-by-count":31,"title":["Next-generation sequencing of pharmacogenes"],"prefix":"10.1097","volume":"23","author":[{"given":"Britt I.","family":"Dr\u00f6gem\u00f6ller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galen E.B.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana J.H.","family":"Niehaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Emsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Warnich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210213","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14656560903508762","article-title":"Pharmacogenetic considerations in the treatment of psychiatric disorders.","volume":"11","author":"Lohoff","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"R3-3-20210213","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/17425255.2011.532787","article-title":"Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.","volume":"7","author":"Zhang","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R4-3-20210213","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/17425255.2013.736964","article-title":"Pharmacogenetics of antipsychotics: recent progress and methodological issues.","volume":"9","author":"Zhang","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R5-3-20210213","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.","volume":"12","author":"Arranz","year":"2007","journal-title":"Mol Psychiatry"},{"key":"R6-3-20210213","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia.","volume":"374","author":"Van Os","year":"2009","journal-title":"Lancet"},{"key":"R7-3-20210213","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/464664a","article-title":"Human genome at ten: life is complicated.","volume":"464","author":"Hayden","year":"2010","journal-title":"Nature"},{"key":"R10-3-20210213","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/clpt.2013.111","article-title":"Challenges in the pharmacogenomic annotation of whole genomes.","volume":"94","author":"Altman","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"R11-3-20210213","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform.","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"R16-3-20210213","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1755-0998.2009.02622.x","article-title":"New generation sequencers as a tool for genotyping of highly polymorphic multilocus MHC system.","volume":"9","author":"Babik","year":"2009","journal-title":"Mol Ecol Resour"},{"key":"R17-3-20210213","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.taap.2005.01.030","article-title":"The human genome project and novel aspects of cytochrome P450 research.","volume":"207","author":"Ingelman-Sundberg","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"R18-3-20210213","doi-asserted-by":"crossref","first-page":"W273","DOI":"10.1093\/nar\/gkh458","article-title":"VISTA: computational tools for comparative genomics.","volume":"32","author":"Frazer","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"R20-3-20210213","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/11595380-000000000-00000","article-title":"Pharmacogenetics of response to antipsychotics in patients with schizophrenia.","volume":"25","author":"Arranz","year":"2011","journal-title":"CNS Drugs"},{"key":"R21-3-20210213","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/ecp.11.16","article-title":"Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.","volume":"4","author":"Arranz","year":"2011","journal-title":"Expert Rev Clin Pharmacol"},{"key":"R22-3-20210213","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2217\/pgs.11.67","article-title":"Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review.","volume":"12","author":"Risselada","year":"2011","journal-title":"Pharmacogenomics"},{"key":"R23-3-20210213","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/mp.2011.109","article-title":"Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.","volume":"17","author":"Lett","year":"2012","journal-title":"Mol Psychiatry"},{"key":"R24-3-20210213","doi-asserted-by":"crossref","first-page":"363","DOI":"10.31887\/DCNS.2009.11.4\/pgerretsen","article-title":"The intersection of pharmacology, imaging, and genetics in the development of personalized medicine.","volume":"11","author":"Gerretsen","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"R25-3-20210213","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/clpt.2011.97","article-title":"Mechanisms and genetics of antipsychotic-associated weight gain.","volume":"90","author":"Balt","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R26-3-20210213","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cll.2010.07.010","article-title":"Pharmacogenetics and schizophrenia.","volume":"30","author":"Foster","year":"2010","journal-title":"Clin Lab Med"},{"key":"R28-3-20210213","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/pgs.11.55","article-title":"Relationship between P-glycoprotein and second-generation antipsychotics.","volume":"12","author":"Moons","year":"2011","journal-title":"Pharmacogenomics"},{"key":"R29-3-20210213","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/00048670801961123","article-title":"Antipsychotic induced weight gain in schizophrenia: mechanisms and management.","volume":"42","author":"Rege","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"key":"R30-3-20210213","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-381328-2.00010-9","article-title":"Genetics of tardive dyskinesia.","volume":"98","author":"Lee","year":"2011","journal-title":"Int Rev Neurobiol"},{"key":"R31-3-20210213","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11920-011-0185-3","article-title":"Genetics of antipsychotic-induced side effects and agranulocytosis.","volume":"13","author":"Chowdhury","year":"2011","journal-title":"Curr Psychiatry Rep"},{"key":"R32-3-20210213","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-1819.2010.02168.x","article-title":"Pharmacogenomics of antipsychotics efficacy for schizophrenia.","volume":"65","author":"Cacabelos","year":"2011","journal-title":"Psychiatry Clin Neurosci"},{"key":"R33-3-20210213","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2174\/138161209788957483","article-title":"Functional imaging as a tool to investigate the relationship between genetic variation and response to treatment with antipsychotics.","volume":"15","author":"Di Giorgio","year":"2009","journal-title":"Curr Pharm Des"},{"key":"R34-3-20210213","doi-asserted-by":"crossref","first-page":"405","DOI":"10.31887\/DCNS.2009.11.4\/tlencz","article-title":"Pharmacogenetics of antipsychotic-induced side effects.","volume":"11","author":"Lencz","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"R35-3-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4306\/pi.2012.9.1.1","article-title":"The pharmacogenetics of symptom response to antipsychotic drugs.","volume":"9","author":"Reynolds","year":"2012","journal-title":"Psychiatry Investig"},{"key":"R36-3-20210213","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1472-8206.2009.00751.x","article-title":"Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.","volume":"24","author":"Blanc","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"R37-3-20210213","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/10673229.2011.581899","article-title":"Pharmacogenetic approaches to cognitive enhancement in schizophrenia.","volume":"19","author":"Burdick","year":"2011","journal-title":"Harv Rev Psychiatry"},{"key":"R38-3-20210213","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2217\/14622416.9.9.1285","article-title":"Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.","volume":"9","author":"Thelma","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R39-3-20210213","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.drudis.2007.07.018","article-title":"The impact of pharmacogenetics on the development and use of antipsychotic drugs.","volume":"12","author":"Reynolds","year":"2007","journal-title":"Drug Discov Today"},{"key":"R42-3-20210213","first-page":"329","article-title":"Personalized antipsychotic treatment: the adverse effects perspectives.","volume":"22","author":"Plesnicar","year":"2010","journal-title":"Psychiatr Danub"},{"key":"R43-3-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.05.025","article-title":"Schizophrenia, just the facts 5. Treatment and prevention. Past, present, and future.","volume":"122","author":"Tandon","year":"2010","journal-title":"Schizophr Res"},{"key":"R45-3-20210213","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1358\/dot.2010.46.8.1509989","article-title":"Iloperidone for the treatment of schizophrenia.","volume":"46","author":"Bishop","year":"2010","journal-title":"Drugs Today (Barc)"},{"key":"R48-3-20210213","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2217\/14622416.8.11.1597","article-title":"CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits.","volume":"8","author":"Dorado","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R49-3-20210213","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2217\/pgs.10.118","article-title":"Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.","volume":"11","author":"Shiroma","year":"2010","journal-title":"Pharmacogenomics"},{"key":"R50-3-20210213","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/09540260701563460","article-title":"Genomics and the future of pharmacotherapy in psychiatry.","volume":"19","author":"Malhotra","year":"2007","journal-title":"Int Rev Psychiatry"},{"key":"R51-3-20210213","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2217\/14622416.9.8.1101","article-title":"Clozapine-induced agranulocytosis and its genetic determinants.","volume":"9","author":"Opgen-Rhein","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R52-3-20210213","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1471-4159.2011.07590.x","article-title":"Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects.","volume":"120","author":"Jafari","year":"2012","journal-title":"J Neurochem"},{"key":"R56-3-20210213","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2217\/pgs.11.119","article-title":"Whole-genome resequencing in pharmacogenomics: moving away from past disparities to globally representative applications.","volume":"12","author":"Drogemoller","year":"2011","journal-title":"Pharmacogenomics"},{"key":"R57-3-20210213","doi-asserted-by":"crossref","first-page":"e59128","DOI":"10.1371\/journal.pone.0059128","article-title":"Comparative studies of copy number variation detection methods for next-generation sequencing technologies.","volume":"8","author":"Duan","year":"2013","journal-title":"PLoS One"},{"key":"R58-3-20210213","doi-asserted-by":"crossref","first-page":"11319","DOI":"10.1073\/pnas.1106996108","article-title":"QnAs with Eric S. Lander. Interview by Prashant Nair.","volume":"108","author":"Lander","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R59-3-20210213","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2217\/pgs.10.15","article-title":"Pharmacogenomics and bioinformatics: PharmGKB.","volume":"11","author":"Thorn","year":"2010","journal-title":"Pharmacogenomics"},{"key":"R61-3-20210213","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1469-1809.2010.00585.x","article-title":"Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population.","volume":"74","author":"Wright","year":"2010","journal-title":"Ann Hum Genet"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T19:21:18Z","timestamp":1716060078000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201312000-00003"}},"subtitle":["a critical analysis focusing on schizophrenia treatment"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000006","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}